Issue #42 Femtech Innovation Sparked by Guidea: Apply for Femovate UX Design Sponsorship

Ignite your Femtech innovation with product & design expertise from Guidea. Apply for sponsorship with the transformative UX design program, Femovate.

Apply for sponsorship

• Kasha, a platform which sells sanitary pads, contraceptives, diapers, and cleaning supplies raised $21M in Series B Funding.
• Berlin-based startup Hale has secured €350K in pre-seed funding to redefine women’s pain management, and to guide genito-pelvic patients throughout their health journey.
• Imagine Solutions Technology has been awarded $1M in funding to build a robust tool for maternal health care, benefiting both patients and medical professionals.
• Wisdom Ventures, a firm with a unique focus on mindfulness, compassion, well-being, and human connection, has closed its inaugural Fund I, raising an $10M.

• A new study found that medical and prescription costs for women aged 45 to 54 experiencing menopause are 47 percent higher on average compared to women in the same age group without menopause. The first saliva-based test for endometriosis has been validated as a diagnostic tool for the condition affecting 190 million women globally.

• Gynecology’s digitalization revolutionizes women’s healthcare, promising better patient care, outcomes, and accessibility, reshaping diagnosis and treatment, making it more personalized and efficient.
• The union health ministry said the Tele-Manas helpline under the National Tele Mental Health Programme has received over 200,000 calls since its launch in October 2022. The number of calls have doubled in just three months.
• Novarti’s Kisqali with endocrine therapy reduces cancer recurrence risk by 25.2%. Study shows consistent results for menopausal and cancer progression statuses.
• Studies believe that Around 70 per cent of womenexperience some sort of mental health issue around menopause. They may experience mood swings, feeling overwhelmed, anxious, and struggle with low confidence, cravings, brain fog, fatigue, and insomnia
• According to industry statistics, Indian digital healthcare market set to hit $8 billion by 2025 per industry stats. Digital health clinics play a vital role, enhancing healthcare access and efficiency in underserved areas

• Miyara, along with IIT-MAA Chennai Chapter is conducting a session on “Health Hacks to Thrive through midlife and beyond”.
• The Woman’s Company was announced as Top D2C Brand by Inc42 Media under the disrupting Indian market category.
• Humm Care is conducting a survey to understand the working parents wellbeing survey to understand the prioritise maternity and family healthcare benefits.
• Archish IVF- Fertility and Wellness Clinic along with FemTech India is hosting the second edition of the Egg Freezing Workshop.

• Israeli medtech company InMode is strengthing its position in the women’s health market through the acquisition of Viveve Medical‘s intellectual property assets.
• MIMOSA™, a first-of-its-kind virtual precision health platform developed by TaraCares Global, has exited its beta phase, as the start-up prepares for launch in 11 international markets.

• Akums Drugs and Pharmaceuticals has secured approval from Drugs Controller General of India for its ground-breaking triple combination diabetes treatment.
• PredOmix is currently preparing for the commercial market launch of its women-specific cancer test which is planned for the latter part of the second quarter of 2023. The test will cover breast, endometrial, cervical, and ovarian cancers.

• Getting vaccinated against shingles could significantly reduce the risk of suffering a stroke or heart attack from the virus, a new study has found. Shingles is caused by the same virus, varicella zoster, that causes chicken pox. People who get chicken pox can develop shingles later in life if the virus becomes active again.
• There is an urgent need for the pharma companies to work on increasing the public awareness regarding clinical trials, as the country is emerging as a key destination for clinical trials due to its large, diverse population and liberalised regulatory landscape, says Global Data, a leading data and analytics company.

• The Union ministry of health and family welfare has said that it has mandated the Indian Council of Medical Research (ICMR), the apex body in the country for formulation, coordination and promotion of biomedical research, to conduct research on the impact of Polypharmacy and others in geriatric population.
• The Pharmacopoeia Commission for Indian Medicine and Homeopathy (PCIM&H) is learnt to have taken steps with the Government of Switzerland to accord recognition for Ayurveda drugs, a category of Asian traditional medicines.